- $168.06m
- $143.19m
- $32.55m
- 47
- 20
- 93
- 53
Annual income statement for MYOMO, fiscal year end - December 31st, USD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | 2024 December 31st | |
|---|---|---|---|---|---|
| Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
| Source: | 10-K | 10-K | 10-K | 10-K | 10-K |
| Standards: | USG | USG | USG | USG | USG |
| Status: | Final | Final | Final | Final | Final |
| Revenue | |||||
| Total Revenue | 7.58 | 13.9 | 15.6 | 19.2 | 32.6 |
| Cost of Revenue | |||||
| Gross Profit | 4.98 | 10.3 | 10.3 | 13.2 | 23.2 |
| Selling / General / Administrative Expenses | |||||
| Research And Development | |||||
| Unusual Expense / Income | |||||
| Total Operating Expenses | 18.8 | 24.1 | 26.2 | 27.5 | 38.8 |
| Operating Profit | -11.2 | -10.3 | -10.7 | -8.23 | -6.21 |
| Total Net Non Operating Interest Income / Expense | |||||
| Total Net Non Operating Interest Income / Expense | |||||
| Other Net Non Operating Costs | |||||
| Net Income Before Taxes | -11.6 | -10.3 | -10.7 | -7.99 | -5.82 |
| Provision for Income Taxes | |||||
| Net Income After Taxes | -11.6 | -10.4 | -10.7 | -8.15 | -6.18 |
| Net Income Before Extraordinary Items | |||||
| Net Income | -11.6 | -10.4 | -10.7 | -8.15 | -6.18 |
| Adjustments to Net Income | |||||
| Income Available to Common Shareholders Excluding Extraordinary Items | |||||
| Income Available to Common Shareholders Including Extraordinary Items | |||||
| Diluted Net Income | -12.2 | -11 | -10.7 | -8.15 | -6.18 |
| Diluted Weighted Average Shares | |||||
| Basic EPS Including Extraordinary Items | |||||
| Diluted EPS Including Extraordinary Items | |||||
| Diluted EPS Excluding Extraordinary Items | |||||
| Normalised Income Before Taxes | |||||
| Normalised Income After Taxes | |||||
| Normalised Income Available to Common Shareholders | |||||
| Diluted Normalised EPS | -3.46 | -1.89 | -1.52 | -0.276 | -0.164 |